Wageningen University & Research, Division of Human Nutrition & Health
Wageningen, Gelderland, 6708 WE, Netherlands
Location status: Recruiting
NCT Number: NCT05473793
A randomized, placebo-controlled, parallel, double-blind trial with three intervention arms and a period of four intervention-weeks that assesses the intake of different dosages of a complex fiber product on bowel function via microbiota changes in subjects that are unsatisfied with their current bowel function.
Interested in participating?
Request Info20 year–80 year
All sexes
Interventional
Not applicable
Wageningen, Gelderland, 6708 WE, Netherlands
Location status: Recruiting
Background: Bowel function issues can have a substantial effect on quality of life. Additional fiber intake might modulate bowel function and gut microbiota, thereby increasing stool frequency and consistency. This could improve defecation ease, feeling of incomplete bowel emptying and bowel function satisfaction. We hypothesize that a dried vegetable, that is naturally high in fiber within plant cells could improve bowel function in subjects with bowel function issues.
Objective: The main objective of the study is to assess whether a dried multifiber vegetable improves bowel function assessed by stool frequency, consistency, defecation ease, feeling of incomplete bowel emptying and satisfaction. Secondary objectives are to assess whether these effects are dose-dependent and associated with the modulation of the gut microbiota and activity. Furthermore, the adaption of bowel function and adaptation of the gut microbiota and activity over time will be analyzed.
Study design: A parallel, randomized, double-blind, placebo-controlled trial of four weeks with one placebo control and three intervention arms that differ in intervention product dose.
Study population: Healthy human volunteers, 20 - 80y old, with bowel function issues reflected in low stool frequency/consistency, difficulty to defecate, and dissatisfaction with their current bowel function.
Intervention: A vegetable product consisting of dried chicory root cubes containing 85% dietary fiber is added to the daily diet. The intervention product is consumed twice daily for four weeks with a maximum dose of 15 g/day. The control (placebo) consists of easily digestible rice puff particles and is consumed in the same manner as the intervention.
Main study parameters/endpoints: Main study outcome are endpoint (week 4) differences from baseline between the highest dose (15 g/day) of the treatment intervention and placebo in bowel function assessed by changes in stool frequency, stool consistency, ease of defecation, incomplete feeling of bowel emptying and bowel function satisfaction. Secondary endpoints are gut microbiota composition and differences in bowel function, quality of life and constipation symptoms assessment between all doses and placebo. Finally, changes over time in gut microbiota and bowel function will be assessed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention product consists of chicory root that have been sliced and dried and are provided in the form of particles (~3mm).
Other names: brand name: WholeFiber™
The control arm receives a placebo consisting of rice puff particles.
Other names: Rice puff particles
Time frame: Change after the intervention of 4 weeks
Bowel function satisfaction is rated on a five-point scale (from "0-not at all" to "4-extremely").
Time frame: Change after the intervention of 4 weeks
Ease of defecation is rated on a five-point scale (from "0-not at all" to "4-extremely").
Time frame: Change after the intervention of 4 weeks
Feeling of incomplete bowel emptying is rated on a five-point scale (from "0-not at all" to "4-extremely").
Time frame: Change after the intervention of 4 weeks
Stool consistency is measured using the Bristol Stool Form Scale (7-point scale from 1=hard to 7=diarrhea).
Time frame: Change after the intervention of 4 weeks
Stool frequency is measured by counting number of bowel movements per week.
Time frame: Change after the intervention of 4 weeks
Measured in fecal samples using DNA sequencing. Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Fecal gut microbiota activity is determined by measuring microbial metabolites in fecal samples among which fermentation products (short-chain fatty acids) using HPLC. Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Quality of life is measured using the questionnaire Patient Assessment of Constipation - Quality of Life. Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Constipation symptoms is measured using the questionnaire Patient Assessment of Constipation - Symptoms. Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Bowel function satisfaction is rated on a five-point scale (from "0-not at all" to "4-extremely").
Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Ease of defecation is rated on a five-point scale (from "0-not at all" to "4-extremely"). Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Feeling of incomplete bowel emptying is rated on a five-point scale (from "0-not at all" to "4-extremely"). Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Stool consistency is measured using the Bristol Stool Form Scale (7-point scale from 1=hard to 7=diarrhea). Compared between different fiber dosages and placebo.
Time frame: Change after the intervention of 4 weeks
Stool frequency is measured by counting number of bowel movements per week. Compared between different fiber dosages and placebo.
Time frame: Weekly development for a period of 4 weeks
Bowel function satisfaction is rated on a five-point scale (from "0-not at all" to "4-extremely"). Compared between different fiber dosages and placebo.
Time frame: Weekly development for a period of 4 weeks
Ease of defecation is rated on a five-point scale (from "0-not at all" to "4-extremely").
Time frame: Weekly development for a period of 4 weeks
Feeling of incomplete bowel emptying is rated on a five-point scale (from "0-not at all" to "4-extremely").
Time frame: Weekly development for a period of 4 weeks
Stool consistency is measured using the Bristol Stool Form Scale (7-point scale from 1=hard to 7=diarrhea).
Time frame: Weekly development for a period of 4 weeks
Stool frequency is measured by counting number of bowel movements per week.
Time frame: Weekly development for a period of 4 weeks
Measured in fecal samples using DNA sequencing.
Time frame: Weekly development for a period of 4 weeks
Fecal gut microbiota activity is determined by measuring microbial metabolites in fecal samples among which fermentation products (short-chain fatty acids) using HPLC.
Interested in participating?
Request InfoWageningen University
Other
The Impact of a Dried Vegetable on Bowel Function and Gut Microbiota in Subjects With Bowel Function Issues
Acronym: HappYFiber
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07588633
Constipation, Functional Constipation (FC)
Osasco, São Paulo, Brazil
View Trial DetailsNCT07545772
Colonic Diseases, Colonic Diseases, Functional
Mesa, Arizona, United States
View Trial DetailsNCT07654959
Anxiety, Anxiety Disorders
Ankara, Turkey (Türkiye)
View Trial DetailsNCT05519683
Colonic Diseases, Colonic Diseases, Functional
Ann Arbor, Michigan, United States
View Trial Details